Parallel Human Immunodeficiency Virus Type 1-Specific CD8 super(+) T-Lymphocyte Responses in Blood and Mucosa during Chronic Infection

• Published in: Journal of virology Vol. 79; no. 7; pp. 4289 - 4297
• Main Authors: Ibarrondo, FJavier, Anton, Peter A, Fuerst, Marie, Ng, Hwee L, Wong, Johnson T, Matud, Jose, Elliott, Julie, Shih, Roger, Hausner, Mary Ann, Price, Charles, Hultin, Lance E, Hultin, Patricia M, Jamieson, Beth D, Yang, Otto O
• Format: Journal Article
• Language: English
• Published: 01.04.2005
• Subjects: Human immunodeficiency virus 1
• ISSN: 0022-538X

Gut-associated lymphoid tissue is the major reservoir of lymphocytes and human immunodeficiency virus type 1 (HIV-1) replication in vivo, yet little is known about HIV-1-specific CD8 super(+) T-lymphocyte (CTL) responses in this compartment. Here we assessed the breadth and magnitude of HIV-1-specific CTL in the peripheral blood and sigmoid colon mucosa of infected subjects not on antiretroviral therapy by enzyme-linked immunospot analysis with 53 peptide pools spanning all viral proteins. Comparisons of blood and mucosal CTL revealed that the magnitude of pool-specific responses is correlated within each individual (mean r super(2) = 0.82 +/-0.04) and across all individuals (r super(2) = 0.75; P < 0.001). Overall, 85.1% of screened peptide pools yielded concordant negative or positive results between compartments. CTL targeting was also closely related between blood and mucosa, with Nef being the most highly targeted (mean of 2.4 spot-forming cells [SFC[/10 super(6) CD8 super(+) T lymphocytes/amino acid [SFC/CD8/aa]), followed by Gag (1.5 SFC/CD8/aa). Finally, comparisons of peptide pool responses seen in both blood and mucosa (concordant positives) versus those seen only in one but not the other (discordant positives) showed that most discordant results were likely an artifact of responses being near the limit of detection. Overall, these results indicate that HIV-1-specific CTL responses in the blood mirror those seen in the mucosal compartment in natural chronic infection. For protective or immunotherapeutic vaccination, it will be important to determine whether immunity is elicited in the mucosa, which is a key site of initial infection and subsequent HIV-1 replication in vivo.